Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (2013 - 2025)

Corbus Pharmaceuticals Holdings' Free Cash Flow history runs 13 years deep, the most recent figure standing at -$15.6 million for Q3 2025.

• On a quarterly basis, Free Cash Flow fell 11.53% year-over-year to -$15.6 million in Q3 2025; TTM through Dec 2025 was -$48.6 million, a 16.81% decrease from a year earlier, with the FY2024 full-year figure at -$41.6 million, down 15.0% from the prior year.
• Free Cash Flow advanced to -$15.6 million in Q3 2025 per CRBP's latest filing, from -$16.6 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $856954.0 in Q3 2021 and bottomed at -$21.8 million in Q1 2021.
• The 5-year median for Free Cash Flow is -$10.6 million (2022), against an average of -$11.2 million.
• Across the five-year window, Free Cash Flow jumped 103.14% in 2021 and slumped 945.44% in 2022, its largest moves.
• Year by year, Free Cash Flow stood at -$9.8 million in 2021, then gained by 23.59% to -$7.5 million in 2022, then grew by 19.26% to -$6.0 million in 2023, then sank by 81.79% to -$10.9 million in 2024, then plunged by 42.11% to -$15.6 million in 2025.
• Per Business Quant, the three latest CRBP Free Cash Flow figures stand at -$15.6 million (Q3 2025), -$16.6 million (Q2 2025), and -$16.4 million (Q1 2025).